Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Syngene International Ltd. ( (IN:SYNGENE) ) just unveiled an announcement.
Syngene International has announced the closure of its trading window for dealings in the company’s securities from April 1, 2026, until 48 hours after the announcement of its audited financial results for the quarter and full year ending March 31, 2026. The move complies with SEBI’s Prohibition of Insider Trading Regulations and the company’s internal code of conduct, signalling standard governance measures to prevent insider trading ahead of key financial disclosures and providing clarity to investors and employees on trading restrictions.
More about Syngene International Ltd.
Syngene International Ltd. is an India-based contract research, development and manufacturing organization serving the global pharmaceutical, biotechnology and other life sciences industries. The company provides discovery, development and manufacturing services from its facilities in Bengaluru, supporting clients across regulated markets.
Average Trading Volume: 98,685
Technical Sentiment Signal: Sell
Current Market Cap: 168.9B INR
See more insights into SYNGENE stock on TipRanks’ Stock Analysis page.